Trump preparing another exec order on drug prices

President Trump is preparing to issue an executive order that would declare a favored nations clause for drug prices, ensuring the U.S. would not pay higher prices than other countries for prescription medications, CNBC reported.

Trump spoke to reporters outside the White House last week, noting that the clause would require the U.S. to pay the same as the country with the lowest prescription drug prices. Following his statement last week, pharmaceutical stocks took a hit.

The order would mirror a proposed rule from HHS to based Medicare payments on an international pricing index, which would set payment for drugs at a target of 126% of what other countries pay.

Trump also recently issued an executive order at the end of June to enable HHS to require hospitals and insurers to disclose negotiated rates for healthcare services, as well as disclose out-of-pocket costs to patients before their procedures. Not all of Trump’s attempts to lower drug prices have been successful. A federal judge recently blocked an HHS rule that would require drugmakers to publish the list prices of drugs in TV ads.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”